Skip to main content
Log in

Mechanism of regulation of immune responses by in vivo administration of monoclonal anti-I-A antibodies

  • Published:
Survey of Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Steinman, L.; Rosenbaum, J.T.; Sriram, S.; McDevitt, H.O.: In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc. natn. Acad. Sci. USA78: 7111 (1981).

    Article  CAS  Google Scholar 

  2. Adelman, N.W.; Watling, D.L.; McDevitt, H.O.: Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies. J. exp. Med.158: 1350 (1983).

    Article  PubMed  CAS  Google Scholar 

  3. Greene, M.I.; Dorf, M.E.; Pierres, M.; Benacerraf, B.: Reduction of syngeneic tumor growth by an anti-I-J allonantiserum. Proc. natn. Acad. Sci. USA74: 5118 (1977).

    Article  CAS  Google Scholar 

  4. Perry, L.L.; Dorf, M.E.; Benacerraf, B.; Greene, M.I.: Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-I-A alloantisera. Proc. natn. Acad. Sci. USA76: 920 (1979).

    Article  CAS  Google Scholar 

  5. Perry, L.L.; Dorf, M.E.; Bach, B.; Benacerraf, B.; Greene, M.I.: Mechanisms of regulation of cell mediated immunity: anti-I-A alloantisera interfere with induction and expression of T cell-mediated immunity to cell bound antigen in vivo. Clin. Immunol. Immunopathol.15: 179 (1980).

    Article  Google Scholar 

  6. Perry, L.L.; Greene, M.I.: The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell-antigen recognition. J. Immun.125: 738 (1980).

    PubMed  CAS  Google Scholar 

  7. Perry, L.L.; Greene, M.I.: Conversion of immunity to suppression by in vivo administration of I-A subregion specific antibodies. J. exp. Med.156: 480 (1982).

    Article  PubMed  CAS  Google Scholar 

  8. Kruisbeck, A.M.; Fultz, M.J.; Sharrow, S.O.; Singer, A.; Mond, J.J.: Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cell but not K/D restricted T cells. J. exp. Med.157: 1932 (1983).

    Article  Google Scholar 

  9. Waldor, M.K.; Sriram, S.; McDevitt, H.O.; Steinman, L.: In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetyl-choline receptors. Proc. natn. Acad. Sci. USA80: 2713 (1983).

    Article  CAS  Google Scholar 

  10. Williams, I.R.; Perry, L.L.: Prolongation of allograft survival by immunotherapy with monoclonal antibodies against host class II MHC antigens. Transplant. Proc. (in press, 1985).

  11. Fultz, M.J.; Scher, I.; Finkelman, F.D.; Kincade, P.; Mond, J.J.: Neonatal suppression with anti-Ia antibody. I. Suppression of murine B lymphocyte development. J. Immun.129: 992 (1981).

    Google Scholar 

  12. Broder, S.D.; Mann, D.L.; Waldmann, T.A.: Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens. J. exp. Med.151: 257 (1979).

    Article  Google Scholar 

  13. Berzofsky, J.A.; Richman, L.K.: Genetic control of the immune response to myoglobins. IV. Inhibition of determinant specific Ir gene-controlled antigen presentation and induction suppression by pretreatment by presenting cells with anti-I-A antibodies. J. Immun.126: 1898 (1981).

    PubMed  CAS  Google Scholar 

  14. Waldor, M.K.; Hardy, R.R.; Hayaka, K.; Steinman, L.; Herzenberg, L.A.: Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies. Proc. natn. Acad. Sci. USA81: 2855 (1984).

    Article  CAS  Google Scholar 

  15. Fultz, M.; Finkelman, F.D.; Mond, J.J.: In vivo administration of anti-I-A antibody induces the internalization of B cell surface I-A and I-E without affecting the expression of surface immunoglobulin. J. Immun.133: 91 (1984).

    PubMed  CAS  Google Scholar 

  16. Lowy, A.; Tominaga, A.; Drebin, J.A.; Takaoki, M.; Benacerraf, B.; Greene, M.I.: Identification of an I-J+ antigen presenting cell required for Ts3 activation. J. exp. Med.157: 353 (1983).

    Article  PubMed  CAS  Google Scholar 

  17. Greene, M.I.; Ratnofsky, S.; Sy, M.S.; Birokoff, S.; Finberg, K.W.: Antigen specific suppression of the cytotoxic T cell response to azobenzenearsonate coupled cells. J. Immun.128: 1188 (1982).

    PubMed  CAS  Google Scholar 

  18. Granstein, R.D.; Lowy, A.; Greene, M.I.: Epidermal antigen presenting cells in activation of suppressor lymphocytes: identification of a new functional type of ultraviolet radiation resistant epidermal cell. J. Immun.132: 563 (1984).

    PubMed  CAS  Google Scholar 

  19. Takaoki, M.; Sy, M.S.; Tominaga, A.; Tsurufuji, M.; Finberg, K.; Benacerraf, B.; Greene, M.I.: I-J restricted interactions in the generation of azobenzenearsonate specific suppressor T cells. J. exp. Med.156: 1325 (1982).

    Article  PubMed  CAS  Google Scholar 

  20. Rosenbaum, J.T.; Adelman, N.E.; McDevitt, H.O.: In vivo effects of antibodies to immune response gene products. I. Haplotype specific suppression of humoral immune responses with a monoclonal anti-I-A antibody. J. exp. Med.154: 1694 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greene, M.I., Perry, L., Carroll, A. et al. Mechanism of regulation of immune responses by in vivo administration of monoclonal anti-I-A antibodies. Surv. immunol. Res. 4, 173–178 (1985). https://doi.org/10.1007/BF02918670

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918670

Keywords

Navigation